Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.
Shaw
Maren G
MG
Department of Dermatology, University of North Carolina at Chapel Hill, NC 27599, USA. mgshaw@unch.unc.edu
Burkhart
Craig N
CN
Morrell
Dean S
DS
D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000628:therapy*; D004643:Emollients / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007223:Infant; D007262:Infusions, Intravenous; D007371:Interferon-gamma / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010789:Phototherapy; D011320:Primary Health Care / Q000379:methods*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D004643:Emollients; D005938:Glucocorticoids; D006633:Histamine Antagonists; D007136:Immunoglobulins; D007155:Immunologic Factors; D007371:Interferon-gamma; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D008727:Methotrexate